A research team at the VIB-KU Leuven Center for Microbiology has developed a novel screening method to identify antimicrobial properties of volatile substances. With this assay, they tested the vapour-phase-mediated activity of 175 essential oils (EOs) and 37 EO components. Approximately half of them proved active against the most drug-resistant type of Candida. In a context of fungi showing increasing drug resistance, these findings may be useful in both medical and agricultural applications.
The research project, led by prof. Patrick Van Dijck, is rooted in the growing problem of antifungal drug resistance. Candida cells, for example, are quickly becoming tolerant to fluconazole, the most-used antifungal drug. Next to exploring experimental new techniques, scientists also seek to repurpose existing substances. Plant essential oils (EOs), metabolites obtained by steam distillation or cold citrus peel pressing, may offer interesting opportunities: they are made up of compounds that help protect the plant against microbial or herbivore attacks.
Identifying EOs and their compounds
In the VIB-KU Leuven Center for Microbiology, Adam Feyaerts gathered a collection of 175 different EOs, constituting a collection of over one thousand different small molecules. The aim was to identify biologically active compounds present in these complex mixtures. They therefore developed a new class of assay that allowed to identify new volatile substances with antifungal activities over a distance.
Prof. Patrick Van Dijck (VIB-KU Leuven): “We screened our whole collection of EOs for vapor-phase mediated antifungal activity against two human fungal pathogens, Candida albicans and Candida glabrata. Interestingly, we found that approximately half of the EOs and their compounds had vapour-phase-mediated activity against bothCandida species. Surprisingly, C. glabrata, the most drug-resistant species of the two was on average even more susceptible. In contrast, none of the currently used antifungals showed any vapour-phase-mediated activity.”
Numerous potential applications
This is now the first simple test to look for the vapor-phase-mediated antimicrobial activity of molecules. The same assay could also be used to test other biological activity. And although these findings still have to be confirmed in clinical trials, potential applications are numerous.
Co-author Adam Feyaerts (VIB-KU Leuven): “Our findings are for instance a starting point for the development of molecules that could also be used in vaporizers. After all, volatiles can access otherwise hard to reach areas. Think of possibilities such as maintaining hygiene in hospitals or treat patients with lung infections. There are agricultural options too, such as preventing post-harvest contamination or protecting crops against pests.”
The Latest on: Antifungal drug resistance
- Lab notes: Poor drug quality is making ringworm treatment less effective on December 11, 2018 at 4:03 pm
Drug resistance may not be the only reason for ... Ringworm (tinea or dermatophytosis) is a type of fungal infection of the skin which can affect both humans and animals. It can occur anywhere ... […]
- Poor quality drugs make treatment of ringworm infection less effective on December 11, 2018 at 4:52 am
Drug resistance may not be the only reason for a drug failing ... Ringworm (tinea or dermatophytosis) is a type of fungal infection of the skin which can affect both humans and animals. It can occur a... […]
- Cloned antibodies show potential to treat, diagnose life-threatening fungal infections on December 11, 2018 at 3:51 am
These therapies are often ineffective on their own and increasingly the infections are becoming resistant to treatment with some of the front line antifungal drugs. Dr Fiona Rudkin, who led the resear... […]
- Antimicrobial Use and Antimicrobial Resistance FAQ on December 9, 2018 at 4:37 am
Antimicrobial use and antimicrobial resistance are hot issues ... such as bacteria (antibacterial), fungi (antifungal), viruses (antiviral), and protozoa (antiprotozoal). Q: What's the difference betw... […]
- Aridis Expands Research Agreement with the Cystic Fibrosis Foundation and is Awarded FDA Expedited Program Designations on December 4, 2018 at 8:30 am
Aridis also announced that the U.S. Food and Drug Administration (FDA ... QIDP Designation is awarded to antibacterial or antifungal product candidates for human use that are intended to treat ... […]
- Lab notes: Seaweed-silver combination can fight drug-resistant bacteria in biofilms on December 4, 2018 at 4:07 am
Antibiotic resistance is a major problem in ... As carrageenan has been widely studied for its antifungal, anti-viral, anti-cancerous and immunomodulatory properties, the nanocomposite based ... […]
- "Onions help against antibiotic resistant bacterial, viral or fungal infections” on November 23, 2018 at 5:34 am
Antibiotic resistance is a deadly threat to modern medicine and to mankind. Now we are in the entrance of post-antibiotic era. Researchers are continuously looking to use plant parts to prevent infect... […]
- Drug Resistance Could Soon Kill More People Each Year Than Cancer, UN Warns on November 13, 2018 at 3:09 am
The United Nations warned today that deaths attributed to resistance to ... viral and fungal infections -- could surpass annual fatalities from cancer in a "global health emergency." To kick off World ... […]
- New Drug Approved for Antibiotic-Resistant Lung Disease on September 30, 2018 at 5:00 pm
"As bacteria continue to grow [resistant] to currently available antibiotics ... new agency rules that encourage development and approval of antibacterial and antifungal drugs to treat certain serious ... […]
- Worldwide emergence of resistance to antifungal drugs challenges human health and food security on May 17, 2018 at 12:26 pm
1 MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London W2 1PG, UK. 2 Department of Biointeractions and Crop Protection, Rothamsted Research, Harp... […]
via Google News and Bing News